MCRM Fertility — An Honest Editorial Review

Chesterfield occupies the western edge of the St. Louis metropolitan area, a prosperous suburb along the Missouri River corridor roughly 25 miles from downtown St. Louis. That positioning matters for fertility patients: MCRM Fertility's clinic at 17300 North Outer Forty draws from Chesterfield and neighboring communities — Wildwood, Ballwin, Ellisville, and Maryland Heights — as well as from patients across greater St. Louis who prefer a suburban setting over traveling into the city. The practice also maintains a Tulsa, Oklahoma location, extending its reach to patients in the Southern Plains region.

Founded in 2013 as the Missouri Center for Reproductive Medicine, MCRM has built one of the more established independent fertility practices in Missouri over the past decade. The clinic carries a 4.5-star Google rating drawn from more than 243 reviews, a pattern consistent with a practice that earns sustained patient loyalty rather than a single wave of positive responses. The clinic operates under the First Fertility Network affiliation while maintaining its local identity and physician continuity. For patients navigating fertility treatment in a state without a mandated insurance coverage law, MCRM's combination of in-house physician expertise, a dedicated on-site laboratory, and transparent financial counseling makes it one of the more substantive options in the St. Louis region. For a broader overview of the Missouri market, see our guide to fertility clinics in Missouri.

Physicians and Clinical Team

MCRM's medical team has more than 50 years of combined experience in reproductive medicine and currently centers on two primary physicians following the retirement of founding physician Dr. Peter Ahlering in March 2026.

Dr. Mira Aubuchon, MD, FACOG — Medical Director and the clinic's primary full-time reproductive endocrinologist, Dr. Aubuchon brings a rigorous academic pedigree to what is fundamentally a community-centered practice. She earned her medical degree from Northwestern University's Feinberg School of Medicine in Chicago (1998), completed her Obstetrics and Gynecology residency at Washington University School of Medicine in St. Louis (2002), and then pursued a three-year fellowship in Reproductive Endocrinology and Infertility at Albert Einstein College of Medicine in New York, finishing in 2005. She is board-certified in both Obstetrics and Gynecology and Reproductive Endocrinology — the dual certification that specifically qualifies a physician to practice as a reproductive endocrinologist and infertility specialist (REI). She serves as an Adjunct Associate Professor of Obstetrics, Gynecology, and Women's Health at the University of Missouri-Columbia School of Medicine and at Saint Louis University, maintaining active academic ties alongside her clinical work. She is also a board examiner for the American Board of Obstetrics and Gynecology, a role that places her among the physicians who set standards for specialty training nationally. Castle Connolly has named her a Top Doctor every year since 2010, including in 2026. Her research spans more than 50 peer-reviewed publications, with particular depth in Polycystic Ovary Syndrome (PCOS) — a specialty area she developed into formal Centers of Excellence at prior institutions.

Dr. Randy Fink, MD, FACOG — Dr. Fink provides reproductive specialist coverage at MCRM, seeing patients on a regular schedule. He completed his undergraduate studies at The American University, earned his medical degree from the Medical College of Virginia, and completed his Obstetrics and Gynecology residency at Brown University / Women & Infants Hospital of Rhode Island — one of the country's most recognized Ob/Gyn training programs. He is board-certified in Obstetrics and Gynecology and brings extensive hands-on experience having managed thousands of fertility cycles across his career. He has been recognized as a Top Doctor in every community he has served, and medical students and residents have repeatedly recognized him for teaching excellence.

The clinical team also includes two board-certified Women's Health Nurse Practitioners: Lauren Rackovan, MSN, APRN, WHNP-BC and Leslie King, MSN, APRN, WHNP-BC. These advanced practice providers handle ongoing care coordination, monitoring appointments, and patient communication, which is a meaningful operational advantage for patients during the intensive monitoring phases of an IVF or egg freezing cycle.

Services and Treatments

MCRM covers the full spectrum of reproductive medicine from initial diagnostic workup through complex third-party reproduction:

• In Vitro Fertilization (IVF) — The clinic's primary treatment pathway, performed in the on-site procedural center and embryology laboratory in Suite 101
• Intracytoplasmic Sperm Injection (ICSI) — Advanced sperm selection technique performed during IVF for male-factor cases or prior fertilization failure
• Intrauterine Insemination (IUI) — First-line treatment for appropriately selected diagnoses including mild male factor, unexplained infertility, and single parents or same-sex couples using donor sperm
• Ovulation Induction — Oral or injectable medication cycles to stimulate ovulation, with or without timed intercourse
• Egg Freezing and Fertility Preservation — Elective preservation for patients not yet ready to conceive, as well as oncofertility coordination for cancer patients facing gonadotoxic treatment
• Embryo Cryopreservation — Freezing and storage of excess embryos for future frozen embryo transfer (FET) cycles
• Preimplantation Genetic Testing (PGT-A and PGT-M) — Aneuploidy screening and single-gene disorder testing to select chromosomally normal embryos before transfer
• Egg Donation — Donor egg cycles managed through the clinic's Matching Miracles program for patients with diminished ovarian reserve, prior poor response, or genetic concerns
• Gestational Carrier / Surrogacy — Clinical management for intended parents working with a gestational carrier
• Donor Sperm Cycles — IUI or IVF using donor sperm for single patients, same-sex female couples, or patients with severe male-factor infertility
• Semen Analysis and DNA Fragmentation Testing — Comprehensive male fertility evaluation including sperm DNA fragmentation studies, which go beyond the standard parameters to assess underlying sperm quality
• LGBTQ+ Family Building — Explicitly supported pathways including reciprocal IVF for female couples and donor-assisted cycles

For a full overview of what to expect at each stage of the IVF process, see our IVF guide.

Laboratory and Success Rates

MCRM's procedural center and embryology laboratory are housed on-site in Suite 101 of the Chesterfield facility, separate from the consultation and monitoring suite on the floor above. Keeping the laboratory in-house — rather than referring patients to an off-site lab or shared facility — is a meaningful clinical distinction, as it allows direct oversight of culture conditions, timing, and embryo handling throughout the stimulation and retrieval cycle.

The clinic uses Embryoscope time-lapse incubators, which photograph embryos at regular intervals without removing them from the stable incubator environment. Time-lapse imaging gives embryologists continuous developmental data to support embryo selection decisions, a technological investment that reflects a commitment to laboratory quality beyond the basic standard. MCRM also employs nanobead sperm selection technology, a technique that isolates sperm with higher DNA integrity from the ejaculate — a clinically relevant refinement for cases where DNA fragmentation may be contributing to fertilization or embryo development issues.

The clinic reports its outcomes data to the Society for Assisted Reproductive Technology (SART) and to the Centers for Disease Control and Prevention (CDC). The most recently available SART data show live birth rates of approximately 60% for patients under 35 using their own eggs, declining to 44.6% for patients aged 35–37, 26% for patients aged 38–40, and 15.6% for patients aged 41–42. These figures reflect approximately 1,797 cycles and are consistent with a clinic performing a meaningful volume of non-traditional stimulation protocols and PGT cycles. As SART notes across all member clinics, patient selection differences mean raw rates are not directly comparable between programs. Patients can review the clinic's full outcomes data directly via the CDC ART Fertility Clinic Success Rates Report.

Patient Experience

What emerges from the sustained review record at MCRM is a practice that has invested in the interpersonal dimensions of fertility care alongside the clinical ones. Patients describe a warm, attentive environment in which care coordinators follow up promptly, physicians take time to explain treatment rationale, and the clinical staff remain composed and supportive during the emotionally demanding phases of treatment — egg retrieval, the two-week wait, and difficult cycle outcomes.

The two-suite setup in Chesterfield is worth understanding as a patient: consultations, ultrasound monitoring, and blood draws occur in Suite 205, while egg retrievals and semen analysis testing are handled in the procedural suite in Suite 101. This physical separation keeps the quieter consultation environment distinct from procedural activity, which some patients find preferable to practices where everything happens in a single-floor, higher-traffic setting.

Monday through Friday hours (8:00 AM to 4:00 PM) are standard for fertility clinics and are workable for most monitoring schedules. The clinic's patient portal and phone-based communication system are described by reviewers as responsive, though as with any busy practice, communication quality during complex or high-stakes cycles can vary. The clinical team's bilingual capabilities and the clear financial counseling process — a separate line for billing at 636-735-3935 — help remove common friction points that frustrate patients at other clinics.

Considering At-Home Insemination?

Not every fertility journey begins in a clinic. At-home intracervical insemination (ICI) is a lower-cost, private option that suits patients with no known fertility diagnosis — including single parents by choice, same-sex couples, and people who want to try a few cycles before committing to clinical treatment.

At-home insemination kits like those from MakeAMom come with step-by-step instructions designed for donor or partner sperm. Kits are a one-time purchase that can be reused until conception succeeds, require no clinic visit, and arrive in plain, discreet packaging. Many patients use them as a first step while working toward a fertility consultation — or alongside ovulation tracking while they wait for an appointment slot.

If you have a known fertility diagnosis, have been trying for 12 months without success (six months if you're over 35), or your physician has already recommended IUI or IVF, a board-certified reproductive endocrinologist is the right next step.

Insurance and Financing

Missouri does not require health insurers to cover fertility treatments, which places it in the majority of U.S. states that leave fertility coverage to the discretion of employers and health plan sponsors. In practical terms, most MCRM patients without employer-sponsored fertility benefits are paying for treatment largely out of pocket.

MCRM employs dedicated financial counselors who work individually with patients to review insurance benefits, identify any applicable coverage, and develop a treatment cost plan before the first cycle begins. This one-on-one approach to financial planning is more substantive than the intake-form-only model used at some practices.

For patients paying out of pocket, MCRM partners with two fertility-focused lenders — PatientFi and CapexMD — both of which offer financing products designed specifically for fertility treatment, including quick approval timelines and fixed monthly payment structures. Patients should request full written cost estimates for their specific protocol, including medication costs and any add-on testing, before committing to a financing plan.

The clinic's Fertility Access Initiative provides up to $2,000 in savings on IVF and egg freezing packages for self-pay patients — a discount structure worth asking about during the financial counseling appointment. Patients with insurance should bring their complete benefit documentation and ask specifically about diagnostic coverage (bloodwork and ultrasound) in addition to treatment coverage, as the two are often handled under different benefit categories.

Frequently Asked Questions

Who are the current physicians at MCRM Fertility in Chesterfield?

As of 2026, the primary treating physicians at MCRM Fertility are Dr. Mira Aubuchon, MD, FACOG (Medical Director; fellowship-trained REI from Albert Einstein College of Medicine; board-certified in both Ob/Gyn and Reproductive Endocrinology; 2026 Castle Connolly Top Doctor) and Dr. Randy Fink, MD, FACOG (residency at Brown University / Women & Infants Hospital; board-certified in Ob/Gyn; extensive fertility cycle experience). Dr. Peter Ahlering, the clinic's founding physician, retired from full-time clinical practice in March 2026. The clinical team also includes NPs Lauren Rackovan, APRN, WHNP-BC and Leslie King, APRN, WHNP-BC.

Does MCRM Fertility accept insurance for IVF or fertility treatments?

Missouri has no fertility insurance mandate, so most patients without employer-sponsored fertility benefits will pay out of pocket. MCRM's financial counselors review each patient's specific insurance plan at the outset to identify any applicable coverage for diagnostics or treatment. Financing is available through PatientFi and CapexMD, and the clinic's Fertility Access Initiative offers up to $2,000 savings on IVF and egg freezing for self-pay patients.

Where is MCRM Fertility located and what are the clinic hours?

The Chesterfield clinic is located at 17300 North Outer Forty, Chesterfield, MO 63005. Suite 205 handles consultations, ultrasounds, and blood draws; Suite 101 houses the procedural center and semen analysis testing. Hours are Monday through Friday, 8:00 AM to 4:00 PM. The phone number is 636-778-9899. MCRM also operates a separate clinic in Tulsa, Oklahoma.

What success rate data is available for MCRM Fertility?

MCRM reports its IVF outcomes annually to SART and the CDC. The most recent available data show live birth rates per intended egg retrieval of approximately 60% for patients under 35 using their own eggs, 44.6% for ages 35–37, and 26% for ages 38–40. These figures cover roughly 1,797 reported cycles. Patients should review the full SART and CDC reports directly and discuss their individual prognosis with Dr. Aubuchon during consultation, as population-level statistics may not reflect outcomes for a specific diagnosis or protocol.